New AI-powered tool uses test results to predict which Barrett's esophagus patients have a high or low risk of developing cancer in the next 5 years.

Moby Strategic Performance and Operational Context. Full-year 2025 revenue growth of 34% (excluding SCC and IDgenetix) was ...

(DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million ...

So, how do you accommodate having a hiatal hernia? Here are some tips: ...

Castle Biosciences, Inc. ( CSTL) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2025 Conference Call. As a reminder, ...

(DecisionDx-Melanoma, TissueCypher) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million Conference call and webcast ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...